Our ongoing studies are directed towards dissecting the different contributions of CCL5–CCR5 interactions in the breast tumour microenvironment, in the context of understanding how metabolic regulation may also influence the immunophenotype–TAM recruitment—and tumour onset and progression. The gene discussed is CCR5; the disease is breast neoplasm.